Key result
The TricValve procedure, a novel transcatheter-based bicaval system, was used as a palliative therapy in a 47-year-old male with severe symptomatic tricuspid regurgitation and right heart failure.
Why the study?
Severe symptomatic TR poses management challenges due to lack of clear medical consensus, high surgical risks, and refractoriness to medical therapy in inoperable patients.
Case Report (n=1)
The TricValve procedure provides a novel transcatheter palliative option for patients with severe symptomatic tricuspid regurgitation and right heart failure who are deemed inoperable.
No takes yet. Share an insight, caveat, or question.
May warrant cautious use in select inoperable cases; leaves open safety and efficacy in prospective trials.
Raghuraman et al. (2024) conducted a case report in Severe symptomatic tricuspid regurgitation (n=1). TricValve procedure was evaluated. The TricValve procedure, a novel transcatheter-based bicaval system, was used as a palliative therapy in a 47-year-old male with severe symptomatic tricuspid regurgitation and right heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: